| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fe2ffac12cb4b804fc7b2e76d5e808f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec107bf3f2a61c27d347266c048c5766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f551727a323a249f118216e5c8fe48c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_348bdbc21bc5dda3bd6eb048354af929 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e834b667e495b7bb3025a6e3586e3d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3b4aefe25b14e754a0c92840e07b3cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2da6b599c1757fd53807c56f7dc90f9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bd8f6b74e3b13778a5296151db15330 |
| publicationDate |
2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010137417-A1 |
| titleOfInvention |
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses |
| abstract |
The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have glucagon receptor antagonist or inverse agonist activity, as well as methods of using these compounds and intermediates and methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising N compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609892-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011124648-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324140-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10829519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017100776-A1 |
| priorityDate |
2005-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |